NOOTROPYL 20 %, oral solution bottle, 125 ml
Brand page: Nootropyl (piracetam) — all forms and strengths in France
Active ingredients: PIRACÉTAM
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 125 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOOTROPYL 20 %, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 125 ml avec mesurette(s) graduée(s)
- Marketing authorisation holder
- ADVANZ PHARMA LIMITED
- Reimbursement according to BDPM
- 15%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>- myoclonie d'origine corticale ; JOURNAL OFFICIEL ; 27/01/12
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 1978
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63426508CIP73209551CIP133400932095513Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIRACÉTAMsolution | 20,000 g · un flacon de 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.